ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products
CHELMSFORD, Mass., June 9 /PRNewswire/ -- ESA Biosciences, a Magellan
Biosciences company and leader in dedicated systems to screen children for
lead poisoning, announced that James P. Whelan
has joined the company as
vice president of sales and marketing for ESA's clinical-diagnostics
TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 1301
...reases reportable compounds and treatment options for clinicians."
continued, "Increasingly, clinicians and researchers are relying on combina...ompany's new Sensititre Xtra Gram Negative MIC Plate (Part No. GNXF), Mr. whelan
said, "Our research-use-only plates help scientists better understand drug ...
Free Early Education Program to Lower Infertility Rates
...s possible thanks to an unrestricted educational grant from Schering-Plough and NYU Fertility Center. Women interested in attending should email Corey whelan
at Corey@theafa.org " target="_new"> Corey@theafa.org or call 718.853.1411.
-- Feb. 10, 2009, East Hills Long Island, ...
Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
...s. Axiom's Partners generate insights and develop recommendations for their clients that have a quantifiable business impact.
Director, Market Development
161 N. Clark Street, Suite 4700
Chicago, IL 60601
e-mail protected from spam bots
10 Minnesota Nursing Homes Named in Class Action Lawsuit Against Extendicare
...is facing a similar class action lawsuit in Washington.
That suit was brought by The Garcia Law Firm of Long Beach, Calif., and by
Stritmatter Kessler whelan
Coluccio of Seattle, Wash., both of whom are
co-counsel with Pearson, Randall, Schumacher & LaBore.
"Stephen Garcia was the first attorney to succes...
The American Fertility Association Announces Plan to Help Young Women Preserve Fertility
...n to help launch this program.
Applications are now being accepted to become a Speaker or Sponsor on a
local or national level. Please contact Corey whelan
at 718.853.1411 or
The American Fertility Association (The AFA), a national non-profit
organization, is a lifetime resource for fe...
Cohera Medical Secures $16.1 Million in Series B Financing
...apital Partners, included
participation from existing investors led by Kern whelan
Capital, LLC. The
angel financing provides the company with sufficient capi... into clinical trials, which are expected to begin early next year.
Capital is delighted to support this second round of
financing by doubling ...
Marex Group Forms Business Development Department and Promotes Three Strategic Employees
...am, but to all of our valued partners."
has assumed the position of Vice President for Strategic Alliances. Mr. whelan
formerly served as Vice President of Marketing for Marex Group, Inc. In his new role Mr. whelan
will have lead responsibility for developing new c...
BioElectronics Corporation's Commercial Resumes on Bloomberg Television
...t the company will
resume airing an investment and product-related commercial on financial
network Bloomberg Television. CEO of BioElectronics, Andrew whelan
"We previously ran this commercial in April with significant success
relating both to our equity and product awareness. We are excited to see
Organizers of cancer clinical trials are neglecting teenagers and young adults
...ts or children through proxy of their parents, but whelan
believes it should be no different.
said: "The problem is not teenagers not wanting to...ot being offered the chance to participate."
and Dr Fern feared that significant improvements i...
Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers
...d exclusively on PPB.
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, whelan
AJ, Williams G, Bracamontes D, Messinger Y, Goodfellow PJ. Germline DICER1 mutations in familial pleuropulmonary blastoma.
Funding from the Si...
BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
...ut the remainder of 2008 and into 2009
as ActiPatch continues to gain increased acceptance in both the domestic
and international marketplaces."
continued, "In order to further drive our future revenue
opportunities, we are aggressively pursuing various clinical studies with
leading medical pro...
Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
...nology for both bacterial and fungal targets along with
SPRI(R) (Solid Phase Reversible Immobilization) and other technologies from
added, "The combination of NUI Galway technologies with ours
gives us a glimpse of the next generation of molecular diagnostics. Our
goal is that our ...
BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
...actors it believes to
be appropriate. Actual results may differ as a result of factors over which
the company has no control.
Contact: Andrew J. whelan
Andrew.Whelan@ActiPatch.net BioElectronics Corporation 4539 Metropolitan Court Frederick, MD 21704 866-757-2284 ext 107 301-874-4890 ext 107 ...
BioElectronics Corp Aggressively Expands Sales into Middle East
...nics Corporation. "There
is well established need for drug free anti inflammatory therapy in the
Middle East which we expect to capture and expand."
explained that Dr. Halawy has had significant sales management
and training experience at Pfizer and several other leading pharmaceutical
BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
... CEO Andrew whelan
to present Corporate Growth Plan on Tuesday, May 20th
FREDERICK, Md., May 15 /PRNewswire-FirstCall/ -- BioElectronics Corp.
(Pink Sheets: BIEL), the...
Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million
...through our affiliate Kern Medical, LLC,
we are delighted to once again lead its investment round," said Jay Kern,
Founder and General Partner of Kern whelan
Capital, LLC, and Manager of
Kern Medical II. "Strong participation by existing investors in this
financing reflects the significant accomplishments t...
BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
... bring the benefits of ActiPatch healing to the people of Italy.
We look forward to a mutually beneficial relationship for years to come,"
said Andrew whelan
of BioElectronics. "TSS Medical will make an official presentation of ActiPatch to the
Italian market at the ESRA Congress in Salerno City later this...
LEDS Bring Relief to Young Cancer Patients
... of chemotherapy and radiation treatments according to Dr. David Margolis, associate professor of pediatrics at the Medical College. He works with Dr. whelan
on the study at Childrens Hospital of Wisconsin, a major teaching affiliate of the Medical College.
Young bone marrow transplant recipients often c...